These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 164185)

  • 21. Inhibition of glucagon-mediated increases in hepatic cyclic adenosine 3', 5'-monophosphate by prostaglandin E1 and E2.
    DeRubertis FR; Zenser TV; Curnow RT
    Endocrinology; 1974 Jul; 95(1):93-101. PubMed ID: 4365622
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.
    Chayoth R; Epstein SM; Field JB
    Cancer Res; 1973 Aug; 33(8):1970-4. PubMed ID: 4352743
    [No Abstract]   [Full Text] [Related]  

  • 23. An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations.
    Heyworth CM; Wallace AV; Wilson SR; Houslay MD
    Biochem J; 1984 Aug; 222(1):183-7. PubMed ID: 6089756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of diabetes and insulin on the rat heart adenyl cyclase, cyclic AMP phosphodiesterase and cyclic AMP.
    Das I
    Horm Metab Res; 1973 Sep; 5(5):330-3. PubMed ID: 4358423
    [No Abstract]   [Full Text] [Related]  

  • 25. A study of the hormonal control in vitro of Na+-K+ activated ATPase of isolated liver plasma membrane.
    Barnabei O; Luly P; Tomasi V; Trevisani A; Tria E
    Adv Enzyme Regul; 1973; 11():273-90. PubMed ID: 4363201
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of prostaglandins on hepatic adenylate cyclase activity and cyclic adenosine 3',5',-monophosphate content.
    Zenser TV; DeRubertis FR; Curnow RT
    Endocrinology; 1974 May; 94(5):1404-10. PubMed ID: 4362972
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostaglandin E1: anomalous effects on glucose production in rat liver.
    Wheeler GE; Epand RM
    Mol Pharmacol; 1975 May; 11(3):335-9. PubMed ID: 167276
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of systematic muscular work on the tissue activity of adenylate cyclase and 3',5'-AMP-phosphodiesterase].
    Iakovlev NN
    Ukr Biokhim Zh; 1974; 46(1):18-24. PubMed ID: 4363030
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of isoprenaline on the phosphodiesterase activity of the rat heart.
    Lahiri RK; Hamid MA; Calvert DN
    J Pharm Pharmacol; 1974 Sep; 26(9):731-2. PubMed ID: 4155752
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein-bound adenosine 3':5'-monophosphate in liver of glucagon-treated rats. Determination of half-maximal binding in vivo and correlation with protein kinase activation.
    Schwoch G; Hilz H
    Eur J Biochem; 1977 Jun; 76(1):269-76. PubMed ID: 195811
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of insulin and growth hormone on rat liver cyclic nucleotide phosphodiesterase.
    Thompson WJ; Little SA; Williams RH
    Biochemistry; 1973 May; 12(10):1889-94. PubMed ID: 4350103
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclic nucleotide phosphodiesterase activity of human liver: is there an altered form in Reye's syndrome?
    Mitchell RA
    Pediatr Res; 1979 Aug; 13(8):945-7. PubMed ID: 225720
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of hormone efficacy in isolated hepatocytes by the intracellular redox state acting on cyclic AMP phosphodiesterase [proceedings].
    Clark MG; Filsell OH; Garrett IG
    J Physiol; 1976 Dec; 263(1):175P-176P. PubMed ID: 189012
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross-talk between glucagon- and adenosine-mediated signalling systems in rat hepatocytes: effects on cyclic AMP-phosphodiesterase activity.
    Robles-Flores M; Allende G; Piña E; García-Sáinz JA
    Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):763-7. PubMed ID: 8554517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver.
    Mayer SE
    J Pharmacol Exp Ther; 1972 Apr; 181(1):116-25. PubMed ID: 4335168
    [No Abstract]   [Full Text] [Related]  

  • 37. Phosphodiesterase activity and the potentiation by theophylline of adrenocorticotrophin stimulated steroidogenesis and adenosine 3',5'-monophosphate levels in isolated rat adrenal cells.
    Mackie C; Schulster D
    Biochem Biophys Res Commun; 1973 Jul; 53(2):545-51. PubMed ID: 4352069
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of cyclic nucleotide phosphodiesterase.
    Appleman MM; Terasaki WL
    Adv Cyclic Nucleotide Res; 1975; 5():153-62. PubMed ID: 165663
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on pyrazinoylguanidine. 4. Upregulation of phosphodiesterase activity in rat adipose tissue and downregulation of gluconeogenesis and adenosine 3',5'-monophosphate concentrations in perfused rat liver.
    A-Rahim YI; Rannels SL; Kimball SR; Beyer KH; Vesell ES
    Pharmacology; 1996 Oct; 53(4):211-8. PubMed ID: 8958559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth hormone and glucagon on ornithine decarboxylase activity and adenosine 3',5'-monophosphate levels in isolated rat hepatocytes.
    Klingensmith MR; Freifeld AG; Pegg AE; Jefferson LS
    Endocrinology; 1980 Jan; 106(1):125-32. PubMed ID: 6243092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.